BioSpace News Archive

Dr Gould brings her substantial expertise and network to the anti-infective company at a crucial time, ahead of entering the clinical stage with lead candidate NOSO-502

Under the terms of the deal, Roivant is paying iNtRON Bio $10 million upfront. iNtRON will be eligible for milestone payments. When the first patient receives treatment in a U.S. Phase II clinical trial scheduled for 2019, the first milestone will be $30 million.

Seqirus, a wholly owned subsidiary of CSL, is expanding its manufacturing plant in North Carolina. It expects to invest $140 million in the expansion.

There are 7 billion people in the world. Of those, 5 billion have access to life-saving medications, while 2 billion do not. That is a gap that pharmaceutical companies can help close through increased R&D programs, logistical initiatives and the lowering of prices, the Access to Medicine Foundation announced Tuesday.

50/50 joint venture with investor syndicate led by Vivo Capital

Futura Medical plc today announces that it will be presenting data on its DermaSys® drug delivery technology and lead product MED20051, a topical glyceryl trinitrate (“GTN”) gel for the treatment of erectile dysfunction (“ED”), at the 19th Annual Fall Scientific Meeting of SMSNA, on 8-11 November 2018 at the Loews Miami Beach Hotel, Miami, Florida USA.

Promore Pharma AB today announced the composition of the Nomination Committee for the Annual General Meeting 2019, which will be held on Tuesday 21 May 2019.

Ultragenyx Pharmaceutical Inc. today announced that it will present at the following upcoming investor conferences

Revolutionary RoboSense RS-IPLS Intelligent Perception LiDAR System is the First Hardware & Software Algorithm Based Solution Created for the Mass Production of Safer Autonomous Vehicles

“Yoga is the most popular complementary health approach in the United States - used by 14.3% of the adult population, or 35.2 million people”, according to a statement published on Centers for Disease Control and Prevention (CDC) website on November eight quoting National Health Interview Survey (NHIS).